Kemin’s immune-health ingredient BetaVia Complete now approved as Novel Food in Thailand
The Thailand Food and Drug Administration (TFDA) approved the algae-derived beta-glucan ingredient in food supplements for humans at a 375-mg daily dose.
Kemin (Des Moines, IA) reports that the Thailand Food and Drug Administration (TFDA) has approved Kemin’s BetaVia Complete immune health ingredient, granting it Novel Food status. The algae-derived beta-glucan ingredient can now be used in food supplements for humans in Thailand at a daily dose of 375 mg.
“BetaVia Complete is derived from Euglena gracilis, Kemin’s proprietary strain of algae known for its high level of beta-1,3-glucan and protein content, which also contains essential fatty acids,” the company’s press release states.
BetaVia also holds regulatory approvals in the U.S. and European Union. The ingredient “helps train the body’s natural defenses, supports respiratory tract health, and protects intestinal barrier integrity,” the press release states.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.
